An innovation this year has been the separation of telecommunication company entries into a separate industry category – the reasoning being that we have found in previous years that this important sector falls uneasily between hi-tech manufacturing, util
Browsing: Logistics & Supply Chain
The High-Technology and Electronics sector has a track record of producing outstanding finalists in these Awards, and very often the overall winner as well. It has sometimes been claimed (regardless of who our assessment partners have been) that the judgi
This category of entry may appear something of a mixed bag – what unites them is that they all work under constraints – legal or regulatory, and of course that great arbiter, public opinion – that can limit their freedom to operate in quite the way that p
We arrived with four finalists in what, we must admit, is a bit of a ”mish-mash” of a category, but is essentially the engineering industries and their supply bases. None the less, the assessors believe they have identified a worthy winner.
The bestLog project, initiated by the European Commission, is making great progress on its way to establishing its core objective – an exchange platform for the improvement of sustainable supply chain management practice across Europe.
The Healthcare category produced four shortlisted finalists, although for reasons that are obscure, one fancied entry didn”t continue through the assessment procedure.
Teamwork can mean almost anything – who hasn”t been baffled by a job application asking you to ”demonstrate teamwork”? It”s safe to say though that any organisation making it onto the shortlist of finalists in these Awards must be displaying teamwork
The Outstanding Contribution category of the European Supply Chain Excellence Awards is very different from all the others: you, our readers, nominate the candidates, and you vote by email for the winner (and none of those shenanigans that other less repu
Pundits and politicians talk about the need for joined-up thinking, and ERP vendors and systems integrators are equally enthisiastic. But just how joined-up are our supply chains in reality?
Bringing new drugs to market is a very expensive business: typically it can cost over €500 million and – given time limitations on patents – the pharmaceuticals company then has just 5-10 years or so to recoup its investment and make a profit for most the
